81 related articles for article (PubMed ID: 1719865)
1. Tachykinins and related peptides in the substantia nigra and neostriatum.
Hökfelt T; Reid M; Herrera-Marschitz M; Ungerstedt U; Terenius L; Håkanson R; Feng DM; Folkers K
Ann N Y Acad Sci; 1991; 632():192-7. PubMed ID: 1719865
[No Abstract] [Full Text] [Related]
2. Differential effects of tachykinins injected intranigrally on striatal dopamine metabolism.
Tan DP; Tsou K
J Neurochem; 1988 Nov; 51(5):1333-7. PubMed ID: 2459306
[TBL] [Abstract][Full Text] [Related]
3. The role of substance P in the nigrostriatal system.
Borison RL; Klawans HL; Diamond BI
Int J Neurol; 1980; 14(2-4):189-94. PubMed ID: 6194132
[No Abstract] [Full Text] [Related]
4. Injection of tachykinins and selective neurokinin receptor ligands into the substantia nigra reticulata increases striatal dopamine and 5-hydroxytryptamine metabolism.
Humpel C; Saria A; Regoli D
Eur J Pharmacol; 1991 Mar; 195(1):107-14. PubMed ID: 1712305
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment with fragments of substance-P or with cholecystokinin differentially affects recovery from sub-total nigrostriatal 6-hydroxydopamine lesion.
Nikolaus S; Huston JP; Schwarting RK
Neural Plast; 1999; 6(4):77-89. PubMed ID: 10714262
[TBL] [Abstract][Full Text] [Related]
6. Effect of the immunoneutralization of substance P in the cat substantia nigra on the release of dopamine from dendrites and terminals of dopaminergic neurons.
Cheramy A; Michelot R; Leviel V; Nieoullon A; Glowinski J; Kerdelhue B
Brain Res; 1978 Oct; 155(2):404-8. PubMed ID: 688024
[No Abstract] [Full Text] [Related]
7. The selective NK3 receptor agonist senktide excites a subpopulation of dopamine-sensitive neurones in the rat substantia nigra pars compacta in vitro.
Keegan KD; Woodruff GN; Pinnock RD
Br J Pharmacol; 1992 Jan; 105(1):3-5. PubMed ID: 1375857
[TBL] [Abstract][Full Text] [Related]
8. Role of striato-nigral substance P in the regulation of the activity of the nigro-striatal dopaminergic neurons.
Glowinski J; Michelot R; Chéramy A
Adv Biochem Psychopharmacol; 1980; 22():51-62. PubMed ID: 6156583
[No Abstract] [Full Text] [Related]
9. Recovery from unilateral 6-hydroxydopamine lesion of substantia nigra promoted by the neurotachykinin substance P 1-11.
Mattioli R; Schwarting RK; Huston JP
Neuroscience; 1992; 48(3):595-605. PubMed ID: 1376454
[TBL] [Abstract][Full Text] [Related]
10. Response of striatonigral substance P systems to a dopamine receptor agonist and antagonist.
Hanson G; Alphs L; Pradhan S; Lovenberg W
Neuropharmacology; 1981 Jun; 20(6):541-8. PubMed ID: 6165922
[No Abstract] [Full Text] [Related]
11. Contribution to the study of nigrostriatal dopaminergic neuron activity using electrochemical detection of dopamine release in the striatum of freely moving animals.
Nieoullon A; Forni C; el Ganouni S
Ann N Y Acad Sci; 1986; 473():126-40. PubMed ID: 3099623
[No Abstract] [Full Text] [Related]
12. Effects of the unilateral nigral modulation of substance P transmission on the activity of the two nigro-striatal dopaminergic pathways.
Michelot R; Leviel V; Giorguieff-Chesselet MF; Chéramy A; Glowinski J
Life Sci; 1979 Feb; 24(8):715-23. PubMed ID: 86931
[No Abstract] [Full Text] [Related]
13. Substance P modulates cocaine-evoked dopamine overflow in the striatum of the rat brain.
Kraft M; Noailles P; Angulo JA
Ann N Y Acad Sci; 2001 Jun; 937():121-31. PubMed ID: 11458533
[TBL] [Abstract][Full Text] [Related]
14. Effect of section of the strionigral fibers on dopamine turnover in the forebrain of the rat.
Bedard P; Larochelle L
Exp Neurol; 1973 Nov; 41(2):314-22. PubMed ID: 4746196
[No Abstract] [Full Text] [Related]
15. Dopaminergic regulation of tachykinin metabolism in the striatonigral pathway.
Li SJ; Sivam SP; McGinty JF; Huang YS; Hong JS
J Pharmacol Exp Ther; 1987 Nov; 243(2):792-8. PubMed ID: 2445959
[TBL] [Abstract][Full Text] [Related]
16. Role of the mesostriatal dopamine pathway.
Strange PG
Trends Neurosci; 1990 Mar; 13(3):93-5. PubMed ID: 1691877
[No Abstract] [Full Text] [Related]
17. Intranigral substance P stimulation of striatal dopamine release is inhibited by spantide II: a new tachykinin antagonist without apparent neurotoxicity.
Reid MS; Hökfelt T; Herrera-Marschitz M; Håkanson R; Feng DM; Folkers K; Goldstein M; Ungerstedt U
Brain Res; 1990 Nov; 532(1-2):175-81. PubMed ID: 1704289
[TBL] [Abstract][Full Text] [Related]
18. Intranigral injection of dynorphin in combination with substance P on striatal dopamine metabolism in the rat.
Tan DP; Tsou K
Brain Res; 1988 Mar; 443(1-2):310-4. PubMed ID: 2451993
[TBL] [Abstract][Full Text] [Related]
19. Substance P antagonists in substantia nigra are anticonvulsant.
Garant DS; Iadarola MJ; Gale K
Brain Res; 1986 Sep; 382(2):372-8. PubMed ID: 2428445
[TBL] [Abstract][Full Text] [Related]
20. Does dopamine contribute to striatal damage caused by impaired mitochondrial function?
Maragos WF; Jakel RJ; Chesnut MD; Geddes JW; Dwoskin LP
Ann N Y Acad Sci; 1999; 893():345-9. PubMed ID: 10672263
[No Abstract] [Full Text] [Related]
[Next] [New Search]
